M&A Deal Summary |
|
|---|---|
| Date | 2019-07-25 |
| Target | Breath Therapeutics |
| Sector | Life Science |
| Buyer(s) | Zambon Company |
| Sellers(s) | GIMV |
| Deal Type | Add-on Acquisition |
| Deal Value | 140M EUR |
SEARCH BY
Try For Free 7-Day Free Trial
Zambon Company S.p.A. is a multicultural group with close links to its local markets and the international research community. Zambon a pharmaceutical and chemical multinational with a reputation for inventive and innovative thinking, flexibility and customer focus.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector (Life Science) | 1 of 1 |
| Type (Add-on Acquisition) | 1 of 1 |
| Country (Germany) | 1 of 1 |
| Year (2019) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2007-11-15 |
Topgen E.S.V.
Brussels, Belgium Topgen, headquartered in Brussels, is a generic pharmaceutical company. The Company has approximately 30 generic registrations and a nationwide sales force that reaches over 4,000 doctors and 3,000 pharmacies. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-07-28 |
Axxam
Bresso, Italy Axxam is an iPRO (innovative Partner Research Organization) and discovery company located in the scientific campus OpenZone. The Company is a provider of discovery services for the entire life sciences industry. Axxam has strong expertise across a broad range of discovery disciplines and innovative technologies, including assay development, compound management, HTS (high-throughput screening) / HCS (high content screening), hit identification and hit validation. Axxam is also engaged in developing novel innovative therapies for diseases with a high unmet medical need. Axxam was founded in 2001 and is based in Bresso, Italy. |
Sell | - |
| Category | Private Equity Firm |
|---|---|
| Founded | 1980 |
| PE ASSETS | 2.0B EUR |
| Size | Large |
| Type | Sector Agnostic |
GIMV is a Belgium based public investment company focused on private equity and venture capital investments in tech-based businesses. GIMV's private equity practice operates through its Corporate Investment unit and targets management buyouts, buy-ins, and growth capital financings of companies with annual sales between EUR15 and EUR150 million. For buyout opportunities GIMV generally takes a majority stake in businesses and for growth capital needs, GIMV takes a minority position. GIMV does not invest in publicly held companies or turnaround situations. GIMV's geographic focus is within Belgium, Netherlands, Germany, and France. GIMV also invests in Russia through Eagle Capital Partners, a partnership with KBC Private Equity. GIMV was formed in 1980 and is headquartered in Antwerp with additional offices in The Hague, Frankfurt, Munich, and Paris.
| DEAL STATS | # |
|---|---|
| Overall | 86 of 97 |
| Sector (Life Science) | 9 of 11 |
| Type (Add-on Acquisition) | 47 of 49 |
| Country (Germany) | 5 of 6 |
| Year (2019) | 3 of 5 |
| Size (of disclosed) | 6 of 12 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-07-01 |
Studiekring
Utrecht, Netherlands Studiekring is a nationwide organization offering supportive education to Dutch youth in cooperation with schools and teachers. Studiekring uses a well-balanced method to improve the study skills of the student and to eliminate knowledge gaps. Studiekring was founded in 2000 and is based in Utrecht, Netherlands. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-07-30 |
thinkstep AG
Leinfelden-Echterdingen, Germany thinkstep AG is a provider of software and consulting services supporting companies globally in sustainability management and reducing their environmental footprint. In the last few years, thinkstep has continuously expanded its impressive customer base and now serves over 2,000 clients in 20 industries, including a large number of Fortune 500 companies in Germany and around the world. |
Sell | - |
